Relative Bioavailability and the Effect of Food on the Bioavailability of LY3337641 in Healthy Subjects
Latest Information Update: 19 Oct 2023
At a glance
- Drugs Poseltinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 20 Jun 2017 Status changed from recruiting to completed.
- 07 Apr 2017 New trial record